Summit Therapeutics Inc. (SMMT)
SMMTNASDAQ-GMBiotechnology: Pharmaceutical Preparations
$17.82
+1.49 (+9.12%) today
Closed, Nov 9, 4:00 PM ET
- Market cap
- $14.27bn
- P/E
- –
- EPS, last 4 quarters
- $-1.07
- Dividend yield
- –
- Day range
- –
- 52-week range
- $12.07 to $29.23
- Average volume
- 6.09m
- Previous close
- $16.33
Analysts
13 coveringBuy8 buy, 5 hold, 0 sell
Targets a year out average $28.35, +59.1% from here
Earnings
next estimate $-0.3600Next report
Dec 2025
-31.8%
Mar 2026
+27.3%
Jun 2026
-7.7%
Sep 2026
+7.1%
estimate reported, and the surprise
Financials
| Quarter | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| Revenue | – | – | – | – |
| Gross profit | – | – | – | – |
| Operating income | -$224.93m | -$195.21m | -$220.50m | -$214.61m |
| Net income | -$219.17m | -$189.42m | -$215.70m | -$208.38m |
News
8 latest- SMMT's Q3 Earnings Beat Estimates, Ivonescimab Development in FocusZacks · 5 days ago
- AZN Q3 Earnings Beat Estimates, Oncology Drugs Drive Sales GrowthZacks · Oct 30, 2026
- Biotech Stocks Facing FDA Decision In November 2026 RTTNews · Oct 29, 2026
- Lunit And Summit Collaborate On AI-Powered Biomarker Discovery For Ivonescimab RTTNews · Oct 26, 2026
- Summit Expands Ivonescimab Development Into Biliary Tract CancerZacks · Oct 22, 2026
- Akeso's Ivonescimab To Be Evaluated In Global Phase II/III Biliary Tract Cancer Trial RTTNews · Oct 21, 2026
- Can Expanding Ivonescimab Development Unlock SMMT's Growth Potential?Zacks · Oct 21, 2026
- SMMT Inks Deal With AZN-Daiichi to Study Ivonescimab + Datroway CombosZacks · Oct 5, 2026
The company
Summit Therapeutics Inc. is a biopharmaceutical oncology company focused on the discovery, development, and commercialization of patient-, physician-, caregiver- and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. Summit was founded in 2003 and the company's shares are listed on the Nasdaq Global Market (symbol 'SMMT').
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Exchange
- NASDAQ-GM
- Region
- North America
- Website
- smmttx.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.